Orbimed Advisors, Stockholder: Passage BIO PASG Planned sale · Filed 25/04/15

Trade details

Type: Planned sale notice
Stock: Passage BIO PASG
Person: Orbimed AdvisorsStockholder
Planned sale date: 25/04/15
Filed: 25/04/15

1.3% of shares outstanding to be sold

Passage BIO trades, last 26 weeks

What else happened in Passage BIO around then

Filed or reported within 30 days of the trade day · 25/03/16~25/05/15

Orbimed Advisors's recent trades

Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21